SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Total Non-Current Liabilities | ₹176 Cr | ₹123 Cr | ₹138 Cr |
What is the latest Total Non-Current Liabilities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹176 Cr |
| Mar2024 | ₹123 Cr |
| Mar2023 | ₹138 Cr |
How is Total Non-Current Liabilities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹176 Cr | 43.07 | |
| Mar2024 | ₹123 Cr | -11.15 | |
| Mar2023 | ₹138 Cr | - | |
Compare Total Non-Current Liabilities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹4,096.8 Cr | 10.2% | 2.2% | -17% | Stock Analytics | |
| SAGILITY INDIA | ₹19,577.3 Cr | 4.7% | 1.2% | -1.3% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹15,748.9 Cr | 0.2% | -2.4% | -45% | Stock Analytics | |
| LATENT VIEW ANALYTICS | ₹6,068.1 Cr | 16.7% | -7.1% | -18.1% | Stock Analytics | |
| JUST DIAL | ₹4,522.3 Cr | 8.8% | 1.6% | -36.3% | Stock Analytics | |
| AWFIS SPACE SOLUTIONS | ₹2,012.8 Cr | 22% | 2.8% | -58.9% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 10.2% |
2.2% |
-17% |
| SENSEX | 1.4% |
-7% |
-3.9% |
You may also like the below Video Courses